ACEi	Angiotensin-Converting Enzyme inhibitors
AD	Alzheimer’s Disease
ADHD	Attention-Deficit/Hyperactivity Disorder
AI	Artificial Intelligence
ALS	Amyotrophic Lateral Sclerosis
AOR	Adjusted Odds Ratio
ARB	Angiotensin II Receptor Blockers
ARG	Alzheimer’s Risk Genes
ATE	Average Treatment Effect
ATSUD	Amphetamine-Type Stimulant Use Disorder
AUC	Area Under the curve
aSyn	Alpha-synuclein
BSL	Baseline
CD	Crohn’s Disease
CI	Confidence Interval
COX-2	Cyclooxygenase-2
DHP-CCB	Dihydropyridine Calcium Channel Blocker
DMF	Dimethyl Fumarate
DPP-4	Dipeptidyl Peptidase-4
ECT	Emulated Clinical Trials
EHR/EMR	Electronic Health Record/Electronic Medical Record
FDA	Food and Drug Administration
FMA	Frequentist Model Averaging
GReX	Gene Expression Profiling
GWAS	Genome-Wide Association Study
HbA1c	Glycated hemoglobin
HR	Hazard Ratio
IBD	Inflammatory Bowel Diseases
IMID	Immune-Mediated Inflammatory Diseases
IPTW	Inverse Probability of Treatment Weighting
IPW	Inverse Probability Weighting
LASSO	Least Absolute Shrinkage and Selection Operator
LTP	Long-Term Potentiation
MeSH	Medical Subject Headings
ML	Machine Learning
MPI	Modeling Path Importance
MS	Multiple Sclerosis
MSM	Marginal Structural Models
NLP	Natural Language Processing
OR	Odds Ratio
OUD	Opioid Use Disorders
PCA	Principal Component Analysis
PD	1. Pharmacodynamic; 2. Parkinson’s Disease
PK	Pharmacokinetic
PSM	Propensity Score Matching
PSW	Propensity Score Weighting
RR	Relative Risk
RWE/RWD	Real-World Evidence/Real-World Data
SSL	Semi-Supervised Learning
T2DM	Type 2 Diabetes Mellitus
UC	Ulcerative Colitis
WHO	World Health Organization